From death sentence to manageable condition: 25 years of Gleevec

🌐 OHSU News — 2026-05-11

The pharmaceutical milestone of Gleevec's 25 years highlights its transformative impact on chronic myeloid leukemia treatment. The ongoing efficacy of this medication underscores advancements in cancer therapies.

Health Gleevec cancer treatment chronic myeloid leukemia pharmaceutical innovation

Read original source →

Single screening sigmoidoscopy linked to lower colorectal cancer risk two decades later
Medical Xpress — 2026-05-11
Cardiac MRI and blood markers sharpen hypertrophic cardiomyopathy risk prediction
Medical Xpress — 2026-05-11
Ebonyi launches Lenacapavir injection for HIV prevention
Premium Times Nigeria — 2026-05-11
Lassa fever death toll hits 190 as fatality rate rises – NCDC
Premium Times Nigeria — 2026-05-11
Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature
MarketWatch — 2026-05-11
Four Australians evacuated from virus-hit ship
The Sydney Morning Herald — 2026-05-11

From death sentence to manageable condition: 25 years of Gleevec

AI Summary

Related Articles

Single screening sigmoidoscopy linked to lower colorectal cancer risk two decades later

Cardiac MRI and blood markers sharpen hypertrophic cardiomyopathy risk prediction

Ebonyi launches Lenacapavir injection for HIV prevention

Lassa fever death toll hits 190 as fatality rate rises – NCDC

Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature

Four Australians evacuated from virus-hit ship